Management of Intraoperative Embolic Stroke During Mitral Valve Repair
If an embolic stroke occurs intraoperatively during mitral valve repair on cardiopulmonary bypass, complete the planned cardiac repair without delay, optimize cerebral perfusion, and avoid heparinization reversal until the procedure is complete.
Immediate Intraoperative Actions
Continue the Cardiac Procedure
- Do not abort or delay completion of the mitral valve repair 1. The cardiac pathology requiring surgery remains life-threatening and must be addressed.
- Complete the valve repair as planned, ensuring optimal surgical result to prevent future embolic events from residual valve pathology 1.
Optimize Cerebral Protection During Bypass
- Maintain adequate cerebral perfusion pressure during cardiopulmonary bypass
- Consider deep anesthesia with agents like pentobarbital for neuroprotection 2
- Ensure proper temperature management during rewarming to avoid inappropriate cerebral temperature gradients 3
- Place patient in Trendelenburg position if air embolism is suspected 2
Minimize Further Embolic Risk
- Meticulously de-air all cardiac chambers before weaning from bypass 4
- Inspect for any residual intracardiac thrombus
- Ensure complete evacuation of air from the left ventricle and aorta through the aortotomy before closure 2
Immediate Post-Bypass Management
Anticoagulation Strategy
- Exercise extreme caution with heparin reversal 1. The guidelines specifically note that heparin should be used cautiously in patients with embolic complications.
- Consider partial rather than complete protamine reversal if bleeding is controlled
- Avoid full anticoagulation for at least 2 weeks to prevent hemorrhagic conversion of the ischemic stroke 1
Prosthesis Selection Consideration
- If the repair fails and valve replacement becomes necessary, strongly prefer bioprosthetic over mechanical valves 1. This avoids the need for mandatory long-term anticoagulation, which carries high risk of hemorrhagic conversion in acute stroke patients.
Early Postoperative Period (First 24-72 Hours)
Neurological Assessment
- Obtain immediate brain CT scan once the patient emerges from anesthesia 1
- Perform brain MRI with diffusion-weighted imaging to determine stroke extent and exclude hemorrhagic conversion 1, 5
- Obtain CT or MR angiography to rule out mycotic aneurysm if any concern for endocarditis exists 1
- Complete neurological examination by neurology consultant 1
Multidisciplinary Team Activation
Immediate discussion with the "endocarditis team" framework applies here 1:
- Cardiac surgery
- Cardiology
- Neurology
- Infectious disease (if any concern for endocarditis)
Anticoagulation Decision-Making
For the first 2 weeks post-stroke:
- No therapeutic anticoagulation regardless of valve type 1
- Monitor closely for hemorrhagic conversion with serial imaging
- Accept the increased short-term thrombotic risk to avoid catastrophic intracranial hemorrhage
After 2 weeks, if bioprosthetic valve was placed:
- Initiate antiplatelet therapy (aspirin 75-100 mg daily) 6, 7
- Consider warfarin for 3-6 months post-implantation, then transition to antiplatelet therapy alone 7
After 2 weeks, if mechanical valve was necessary:
- Gradually initiate warfarin with careful INR monitoring 7
- Target INR 2.5-3.0 for aortic position, 2.5-3.5 for mitral position 7
- Consider adding low-dose aspirin (75-100 mg) once stroke is stable and no hemorrhagic conversion 7
Critical Pitfalls to Avoid
Do not abort the cardiac surgery - The original cardiac pathology remains immediately life-threatening 1
Do not give full-dose anticoagulation immediately postoperatively - This dramatically increases hemorrhagic conversion risk in acute ischemic stroke 1
Do not place a mechanical valve if avoidable - Bioprosthetic valves eliminate the mandatory anticoagulation requirement during the high-risk hemorrhagic conversion period 1
Do not delay neuroimaging - Early CT and MRI are essential to guide anticoagulation decisions and detect hemorrhagic conversion 1, 5
Do not assume the stroke precludes good recovery - Modern evidence shows that early cardiac surgery after ischemic stroke (without hemorrhagic conversion) does not worsen neurological outcomes 5, 1
Evidence Quality Note
The strongest guideline evidence 1 from Circulation (2016) specifically addresses embolic stroke during cardiac surgery for endocarditis, but the principles directly apply to intraoperative embolic events during mitral valve repair. The key recommendation is that ischemic strokes without significant hemorrhagic conversion should not delay necessary cardiac surgery, and by extension, should not cause abortion of ongoing cardiac surgery. The 2021 ACC/AHA valvular guidelines 7 and 2015 AHA endocarditis statement 5 provide concordant recommendations regarding anticoagulation timing and prosthesis selection in stroke patients.